STOCKSIntercept Sinks on Safety Issue, One Analyst Says Buy Anyway - Biotech MoversBy Armie Margaret LeeSep 22, 2017 12:13 PM EDT
STOCKSTwitter is one of five stocks insiders really love right nowBy Roberto PedoneFeb 15, 2017 2:04 PM EST
HOW-TODon't tell anyone, but insiders are buying these stocks like crazyBy Roberto PedoneJan 8, 2017 11:20 AM EST
STOCKS16 Biopharma Companies Besides Medivation That Are Attractive TargetsBy Sarah PringleJun 29, 2016 1:28 PM EDT
TECHNOLOGYVersartis Price Gains on Drug Approval, eHealth Rises: Tech Winners & LosersBy James RubinJul 6, 2015 5:18 PM EDT
